Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

被引:0
|
作者
Pieter Jelle Visser
Lianne M. Reus
Johan Gobom
Iris Jansen
Ellen Dicks
Sven J. van der Lee
Magda Tsolaki
Frans R. J. Verhey
Julius Popp
Pablo Martinez-Lage
Rik Vandenberghe
Alberto Lleó
José Luís Molinuevo
Sebastiaan Engelborghs
Yvonne Freund-Levi
Lutz Froelich
Kristel Sleegers
Valerija Dobricic
Simon Lovestone
Johannes Streffer
Stephanie J. B. Vos
Isabelle Bos
August B. Smit
Kaj Blennow
Philip Scheltens
Charlotte E. Teunissen
Lars Bertram
Henrik Zetterberg
Betty M. Tijms
机构
[1] Vrije Universiteit Amsterdam,Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience
[2] Maastricht University,Alzheimer Center Limburg, School for Mental Health and Neuroscience
[3] Karolinska Institutet,Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics
[4] Sahlgrenska University Hospital,Clinical Neurochemistry Laboratory
[5] Sahlgrenska Academy at the University of Gothenburg,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology
[6] VU University,Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience
[7] Vrije Universiteit Amsterdam,Section Genomics of Neurodegenerative Diseases and Aging, Department of Clinical Genetics
[8] Amsterdam UMC,1St Department of Neurology
[9] AHEPA University Hospital,Old Age Psychiatry
[10] University Hospital Lausanne,Department of Geriatric Psychiatry
[11] University Hospital of Psychiatry and University of Zürich,Laboratory for Cognitive Neurology, Department of Neurosciences
[12] Fundación CITA-Alzhéimer Fundazioa,IIB
[13] Neurology Service,Sant Pau, Hospital de La Santa Creu I Sant Pau
[14] University Hospitals Leuven,Reference Center for Biological Markers of Dementia (BIODEM), Institute Born
[15] KU Leuven,Bunge
[16] Universitat Autonoma de Barcelona,Department of Neurology, UZ Brussel and Center for Neurosciences
[17] Barcelonaβeta Brain Research Center (BBRC),Department of Psychiatry at School of Medical Sciences
[18] Alzheimer’s Disease Unit and Other Cognitive Disorders Unit,Department of Geriatric Psychiatry, Zentralinstitut Für Seelische Gesundheit
[19] Hospital Clinic de Barcelona,Department of Biomedical Sciences
[20] University of Antwerp,Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics and Cardiogenetics
[21] Vrije Universiteit Brussel,Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience
[22] Örebro University,Neurochemistry Laboratory, Department of Clinical Chemistry
[23] University of Heidelberg,Center for Lifespan Changes in Brain and Cognition, Dept. of Psychology
[24] Complex Genetics Group,Department of Neurodegenerative Disease
[25] VIB Center for Molecular Neurology,undefined
[26] VIB,undefined
[27] University of Antwerp,undefined
[28] University of Lübeck,undefined
[29] Jansen UK,undefined
[30] AC Immune SA,undefined
[31] Vrije Universiteit Amsterdam,undefined
[32] Amsterdam University Medical Centers (AUMC),undefined
[33] Amsterdam Neuroscience,undefined
[34] University of Oslo,undefined
[35] UCL Institute of Neurology,undefined
[36] Dementia Research Institute at UCL,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease
    Gangishetti, Umesh
    Howell, J. Christina
    Perrin, Richard J.
    Louneva, Natalia
    Watts, Kelly D.
    Kollhoff, Alexander
    Grossman, Murray
    Wolk, David A.
    Shaw, Leslie M.
    Morris, John C.
    Trojanowski, John Q.
    Fagan, Anne M.
    Arnold, Steven E.
    Hu, William T.
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [32] Tau, phospho-tau and Ab42 in cerebrospinal fluid in Alzheimer's disease
    Blennow, K
    EUROPEAN PSYCHIATRY, 2002, 17 : 77S - 77S
  • [33] Cerebrospinal fluid levels of insulin in patients with Alzheimer's disease
    Molina, JA
    Jiménez-Jiménez, FJ
    Vargas, C
    Gómez, P
    de Bustos, F
    Gómez-Escalonilla, C
    Zurdo, M
    Tallón, A
    Martínez-Salio, A
    Porta-Etessam, J
    Villanueva, C
    Arenas, J
    ACTA NEUROLOGICA SCANDINAVICA, 2002, 106 (06): : 347 - 350
  • [34] Cerebrospinal fluid nitrate levels in patients with Alzheimer's disease
    Navarro, JA
    Molina, JA
    JimenezJimenez, FJ
    BenitoLeon, J
    OrtiPareja, M
    Gasalla, T
    CabreraValdivia, F
    Vargas, C
    deBustos, F
    Arenas, J
    ACTA NEUROLOGICA SCANDINAVICA, 1996, 94 (06): : 411 - 414
  • [35] Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease
    J. A. Molina
    F. J. Jiménez-Jiménez
    A. Hernánz
    E. Fernández-Vivancos
    S. Medina
    F. de Bustos
    C. Gómez-Escalonilla
    Y. Sayed
    Journal of Neural Transmission, 2002, 109 : 1035 - 1044
  • [36] Increased cerebrospinal fluid cAMP levels in Alzheimer's disease
    Martínez, M
    Fernández, E
    Frank, A
    Guaza, C
    de la Fuente, M
    Hernanz, A
    BRAIN RESEARCH, 1999, 846 (02) : 265 - 267
  • [37] Cerebrospinal fluid levels of selenium in patients with Alzheimer's disease
    Meseguer, I
    Molina, JA
    Jiménez-Jiménez, FJ
    Aguilar, MV
    Mateos-Vega, CJ
    González-Muñoz, MJ
    de Bustos, F
    Ortí-Pareja, M
    Zurdo, M
    Berbel, A
    Barrios, E
    Martínez-Para, MC
    JOURNAL OF NEURAL TRANSMISSION, 1999, 106 (3-4) : 309 - 315
  • [38] Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease
    Rubio, JC
    de Bustos, F
    Molina, JA
    Jiménez-Jiménez, FJ
    Benito-León, J
    Martín, MA
    Campos, Y
    Ortí-Pareja, M
    Cabrera-Valdivia, F
    Arenas, J
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 155 (02) : 192 - 195
  • [39] Cerebrospinal fluid levels of phosphotau in patients with Alzheimer's disease
    Sakka, P
    Nikolaou, C
    Lymperopoulou, O
    Efthymiou, A
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S299 - S299
  • [40] Cerebrospinal fluid levels of selenium in patients with Alzheimer's disease
    I. Meseguer
    J. A. Molina
    F. J. Jiménez-Jiménez
    M. V. Aguilar
    C. J. Mateos-Vega
    M. J. González-Muñoz
    F. de Bustos
    M. Ortí-Pareja
    M. Zurdo
    A. Berbel
    E. Barrios
    M. C. Martínez-Para
    Journal of Neural Transmission, 1999, 106 : 309 - 315